Over 55 million people worldwide are living with dementia, with Alzheimer’s disease (AD) accounting for approximately 70% of all cases. Despite decades of research, truly effective and accessible treatments remain elusive - leaving families and caregivers with limited options as cognitive decline progresses.

NeuroPod is a revolutionary at-home neuromodulation device designed to address this urgent need. Through a combination of radiofrequency stimulation, photobiomodulation, and gamma-frequency entrainment, NeuroPod delivers non-invasive neuromodulation to deep brain regions critically involved in memory, attention, and executive function that are progressively impaired in Alzheimer’s disease.

These neuromodulations have shown promising improvements in cognitive clarity, attention, and daily function.

While some drugs may offer temporary relief of symptoms, many individuals continue to struggle with progressive cognitive and behavioral decline that disrupts independence, communication, and overall quality of life. NeuroPod offers a non-invasive, personalized, and science-driven solution that fits seamlessly into patients' daily routines.

We are preparing for pivotal clinical trials to validate the safety and long-term efficacy of NeuroPod. Our goal is to empower individuals with Alzheimer’s - and those who care for them - with a new pathforward rooted in innovation and hope.

Join us in redefining what’s possible in Alzheimer’s care.